Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
3.96
0.10 (2.59%)
At close: May 16, 2025, 3:59 PM
3.91
-1.26%
After-hours: May 16, 2025, 05:49 PM EDT
Avalo Therapeutics Revenue
Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending March 31, 2025, Avalo Therapeutics generated $0 in revenue.
Revenue (ttm)
$441K
Revenue Growth
-77.08%
Price / Sales Ratio
136.95
Revenue / Employee
$19.17K
Employees
23
Market Cap
42.88M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|